HemaPrompt Gastric is a guaiac-based in-vitro slide method for the qualitative detection of occult blood gastric aspirate or vomitus by medical professionals only. For the testing of gastric contents it is used for the detection of occult blood in conditions such as gastric trauma, gastric or duodenal ulceration, gastric cancer, esophageal varices, situations of likely exogenous or endogenous gastritis, leukemia, and hereditary telangiectasia. These conditions may be encountered in the emergency room, recovery room or intensive care.
Device Story
HemaPrompt Gastric is a guaiac-based in-vitro slide test for qualitative detection of occult blood in gastric aspirate or vomitus. Device consists of buffered guaiac-impregnated paper on a cardboard frame. Medical professionals apply gastric sample to one side; developer solution is applied to reverse side. Presence of hemoglobin (>100 mcg/ml) catalyzes pseudoperoxidase reaction, turning paper blue within 60 seconds. Includes internal monitors to verify chemical function. Used in clinical settings like ER, recovery, or ICU to assist in identifying gastric bleeding associated with trauma, ulcers, cancer, or other pathologies. Provides rapid visual qualitative result to inform clinical assessment of gastrointestinal health.
Clinical Evidence
Bench testing only. Analytical performance evaluated using 35 gastric samples; 100% precision for hemoglobin levels >100 mcg/ml. Analytical specificity tested across pH range 1.0–7.0 with various medications; no interference observed. Method comparison against predicate device showed 100% agreement for hemoglobin levels >100 mcg/ml. Detection limit is 50 mcg/ml. False positive rate of 25.5% reported in normal patients.
Technological Characteristics
Guaiac-impregnated paper test slide; includes separate pH indicator paper. Principle: peroxidase-like reaction of hemoglobin with guaiac in the presence of hydrogen peroxide developer. Qualitative visual readout (blue color). Standalone, non-electronic, single-use diagnostic test.
Indications for Use
Indicated for medical professionals to qualitatively detect occult blood in gastric aspirate or vomitus in patients with conditions including gastric trauma, ulceration, cancer, esophageal varices, gastritis, leukemia, or hereditary telangiectasia.
Regulatory Classification
Identification
An occult blood test is a device used to detect occult blood in urine or feces. (Occult blood is blood present in such small quantities that it can be detected only by chemical tests of suspected material, or by microscopic or spectroscopic examination.)
Special Controls
*Classification.* Class II (special controls). A control intended for use with an occult blood test is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 864.9.
Related Devices
K972763 — HEMAPROMPT · Aerscher Diagnostics · Oct 20, 1997
K163554 — hema-screen ER XCEL Enhanced Readability Fecal Occult Blood Test · Immunostics Inc., · Jan 17, 2017
K102664 — HEMA SCREEN ER · Immunostics Inc., · Jan 28, 2011
K984269 — DBEST OCCULT BLOOD TEST KIT · Ameritek, Inc. · May 11, 1999
Submission Summary (Full Text)
{0}
510(k) SUBSTANTIAL EQUIVALENCE DETERMINATION
DECISION SUMMARY
DEVICE ONLY TEMPLATE
A. 510(k) Number:
K031356
B. Analyte:
Hemaprompt Gastric
C. Type of Test:
HemaPrompt Gastric is a guaiac-based in-vitro slide method for the qualitative detection of occult blood gastric aspirate or vomitus by medical professionals only.
D. Applicant:
Aerscher Diagnostic
E. Proprietary and Established Names:
F. Regulatory Information:
1. Regulation section:
21 CFR Part 864.6550 Reagent Occult Blood
2. Classification:
Class II
3. Product Code:
KHE
4. Panel:
Hematology (81)
G. Intended Use:
1. Indication(s) for use:
HemaPrompt Gastric is a guaiac-based in-vitro slide method for the qualitative detection of occult blood gastric aspirate or vomitus by medical professionals only. For the testing of gastric contents it is used for the
{1}
Page 2 of 4
detection of occult blood in conditions such as gastric trauma, gastric or duodenal ulceration, gastric cancer, esophageal varices, situations of likely exogenous or endogenous gastritis, leukemia, and hereditary telangiectasia. These conditions may be encountered in the emergency room, recovery room or intensive care.
2. Special condition for use statement(s):
N/A
3. Special instrument Requirements:
N/A
## H. Device Description:
HemaPrompt Gastric is a version of the laboratory guaiac slide test for gastric occult blood, and is composed of buffered guaiac-impregnated paper mounted on a cardboard frame which permits sample applications to one side with development and interpretation from the reverse side. Gastric contents containing occult blood contacts the guaiac impregnated paper and a pseudoperoxidase reaction occurs when developing solution is brought into contact with the guaiac paper. The test paper will turn blue in the presence of more than 100 mcg hemoglobin/ml of gastric fluid in less than 60 seconds. Monitors on the guaiac slide indicate if the chemicals are functioning correctly.
## I. Substantial Equivalence Information:
1. Predicate device name(s):
HemaPrompt fg
2. Predicate K number(s):
K9972763
3. Comparison with predicate:
| Similarities | | |
| --- | --- | --- |
| Item | Device | Predicate |
| Guaiac-peroxidase reaction slide test | Same | Same |
| Differences | | |
| Item | Device | Predicate |
| Developing Solution | External dropper | Pregnated on slide |
| pH Indicator | External-included | Not included |
| Sample type | Gastric | Stool |
{2}
Page 3 of 4
## J. Standard/Guidance Document Referenced (if applicable):
## K. Test Principle:
The use of guaiac as a test for the presence of blood is based on the oxidation of phenolic compounds present in guaiac to quinines, resulting in the production of a blue color. If blood is present, the heme portion of the hemoglobin (Hgb) molecule can function in a pseudoenzymatic manner, catalyzing the release of oxygen from hydrogen peroxide which in turn causes the oxidation of guaiac.
## L. Performance Characteristics (if/when applicable):
### 1. Analytical performance:
a. Precision/Reproducibility:
A total of 35 gastric samples were tested 4 times the same day, and 3 subsequent days on the same samples with 100% precision for levels above 100 mcg/ml of hemoglobin. A 50% precision was seen in levels less than 50 mcg/ml of hemoglobin.
b. Linearity/assay reportable range: N/A
c. Traceability (controls, calibrators, or method): N/A
d. Detection limit:
50 mcg/ml of hemoglobin or greater
e. Analytical specificity:
Twenty batches of gastric juice obtained by aspiration from different individuals, ten with gastric pathology and ten from healthy volunteers. Each sample was divided into 5 further samples and the pH in each adjusted to produce samples at pH 1.0, 2.5, 4.0, 6.0, and 7.0 respectively (simulating the varying pHs likely to be encountered in gastric juices). Each of these samples had blood added to provide hemoglobin levels of 5.0, 10, 50, 100, 200, 500, mcg hemoglobin/ml gastric juice. In addition these samples were tested for cross reactivity with Ranitidine HCI (Zantac) 25 mg/ml per 150ml gastric juice, Ferrous Sulfate Liquid USP 60 mg/ml per 150 ml gastric juice, and Mylanta 10-20 ml per 150 ml gastric juice.
Conclusion: The reaction levels are not affected by pH (range 1-7), nor by ferrous sulfate, Zantac or Mylanta when taken at recommended doses.
{3}
Page 4 of 4
f. Assay cut-off:
N/A
2. Comparison studies:
a. Method comparison with predicate device:
Twenty batches of gastric juice obtained by aspiration from different individuals, ten with gastric pathology and ten from healthy volunteers. Each sample was divided into 5 further samples and the pH in each adjusted to produce samples at pH 1.0, 2.5, 4.0, 6.0, and 7.0 respectively (simulating the varying pHs likely to be encountered in gastric juices). Each of these samples had blood added to provide hemoglobin levels of 5.0, 10, 50, 100, 200, 500, mcg hemoglobin/ml gastric juice. Compared to the HemaPrompt fg, levels of hemoglobin above 100 mcg/ml showed 100% agreement reaction within 60 seconds and 50% agreement for 50 mcg/ml and below.
b. Matrix comparison:
Gastric juice
3. Clinical studies:
a. Clinical sensitivity:
b. Clinical specificity:
c. Other clinical supportive data (when a and b are not applicable):
4. Clinical cut-off:
5. Expected values/Reference range:
Negative, however there is a false positive rate of 25.5% in normal patients
M. Conclusion:
Based on the studies included in this study, I recommend the HemaPrompt Gastric is SE to the predicate.
Panel 1
/
Ready
Predicate graph will load when search results are available.
Embedding visualization will load when search results are available.
PDF viewer will load when search results are available.
Loading panels...
Select an item from Submissions
Click any panel, subpart, regulation, product code, or device to see details here.
Section Matches
Results will appear here.
Product Code Matches
Results will appear here.
Special Control Matches
Results will appear here.
Loading collections...
Loading
My Alerts
You will receive email notifications based on the filters and frequency you set for each alert.
Sort by:
Create Alert
Search Filters
Agent Token
Create a read-only bearer token for Claude, ChatGPT, or other agents that can call HTTP APIs.